{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:12:02Z","timestamp":1792807922268,"version":"4.5.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T00:00:00Z","timestamp":1544400000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02901","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T00:18:37Z","timestamp":1544401117000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":73,"title":["Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis"],"prefix":"10.3389","volume":"9","author":[{"given":"Yusuke","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Nakayamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ippei","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulzhan","family":"Trimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/art.23148","article-title":"Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis","volume":"58","author":"van","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"14447","DOI":"10.1073\/pnas.95.24.14447","article-title":"Perturbation of the T cell repertoire in rheumatoid arthritis","volume":"95","author":"Wagner","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J Exp Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat Med."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/ar4347","article-title":"A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis","author":"Martin","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/art.38617","article-title":"A Phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors","volume":"66","author":"Genovese","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.2147\/DDDT.S105263","article-title":"Secukinumab for rheumatology: development and its potential place in therapy","volume":"10","author":"Koenders","year":"2016","journal-title":"Drug Des Dev Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1172\/JCI40202","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J Clin Invest."},{"key":"B11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1767","article-title":"Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells","volume":"10","author":"Trifari","year":"2009","journal-title":"Nat Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.4049\/jimmunol.1601480","article-title":"Th22 cells form a distinct Th lineage from Th17 cells in vitro with unique transcriptional properties and Tbet-dependent Th1 plasticity","volume":"198","author":"Plank","year":"2017","journal-title":"J Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1002\/eji.201040461","article-title":"Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells","volume":"40","author":"Ramirez","year":"2010","journal-title":"Eur J Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00281-009-0188-x","article-title":"Biology of interleukin-22","volume":"32","author":"Wolk","year":"2010","journal-title":"Semin Immunopathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrd4176","article-title":"Therapeutic opportunities of the IL-22-IL-22R1 system","volume":"13","author":"Sabat","year":"2014","journal-title":"Nat Rev Drug Discov."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.4049\/jimmunol.1202677","article-title":"Role of IL-22- and TNF-\u03b1-producing Th22 cells in uveitis patients with Behcet's disease","volume":"190","author":"Sugita","year":"2013","journal-title":"J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e31000","DOI":"10.1371\/journal.pone.0031000","article-title":"Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS ONE"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/art.33446","article-title":"Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3389\/fimmu.2015.00384","article-title":"T cell migration in rheumatoid arthritis","volume":"6","author":"Mellado","year":"2015","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J Exp Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1136\/annrheumdis-2015-207477","article-title":"IL-22 capacitates dermal fibroblast responses to TNF in scleroderma","volume":"75","author":"Brembilla","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/rheumatology\/keu005","article-title":"Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity","volume":"53","author":"Ciccia","year":"2014","journal-title":"Rheumatology"},{"key":"B24","first-page":"108","article-title":"Th22 cells in autoimmunity: a review of current knowledge","volume":"47","author":"Azizi","year":"2015","journal-title":"Eur Ann Allergy Clin Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/mi.2013.31","article-title":"IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue","volume":"7","author":"Leung","year":"2014","journal-title":"Mucosal Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/art.24220","article-title":"Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL\/6 mice","volume":"60","author":"Geboes","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1002\/art.37849","article-title":"IL-22 reduces the severity of collagen arthritis in association with increased levels of IL-10","volume":"257","author":"Chalovich","year":"2005","journal-title":"Biophys Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells","volume":"327","author":"Auf","year":"2010","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cyto.2012.03.024","article-title":"The promotional effect of IL-22 on mineralization activity of periodontal ligament cells","volume":"59","author":"Kato-Kogoe","year":"2012","journal-title":"Cytokine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+ CD4\u2212 CD8\u2212 entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"33676","DOI":"10.1074\/jbc.M204204200","article-title":"Interleukin-22 (IL-22) activates the JAK\/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line: pathways that are shared with and distinct from IL-10","volume":"277","author":"Lejeune","year":"2002","journal-title":"J Biol Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1053\/j.gastro.2005.06.071","article-title":"Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts","volume":"129","author":"Andoh","year":"2005","journal-title":"Gastroenterology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/jid.2012.463","article-title":"IL-22 promotes fibroblast-mediated wound repair in the skin","volume":"133","author":"McGee","year":"2013","journal-title":"J Invest Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.7150\/ijbs.13814","article-title":"Selective regulation of MAPK signaling mediates RANKL-dependent osteoclast differentiation","volume":"12","author":"Lee","year":"2016","journal-title":"Int J Biol Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2174\/1568010054022015","article-title":"Osteoblasts and osteoclasts in bone remodeling and inflammation","volume":"4","author":"Tanaka","year":"2005","journal-title":"Curr Drug Targets"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02901\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T00:18:39Z","timestamp":1544401119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02901\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,10]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2018.02901"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02901","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,10]]},"article-number":"2901"}}